Publication Information

{'id': 'https://openalex.org/W2412271360', 'doi': None, 'title': '[Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].', 'display_name': '[Rebound of prostate specific antigen after discontinuation of antiandrogen therapy for benign prostatic hyperplasia].', 'publication_year': 2000, 'publication_date': '2000-09-01', 'ids': {'openalex': 'https://openalex.org/W2412271360', 'mag': '2412271360', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11107528'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11107528', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5108553687', 'display_name': 'K Noguchi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I89630735', 'display_name': 'Yokohama City University', 'ror': 'https://ror.org/0135d1r83', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I89630735']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Noguchi K', 'raw_affiliation_strings': ['Department of Urology, Yokohama City University, School of Medicine.'], 'affiliations': [{'raw_affiliation_string': 'Department of Urology, Yokohama City University, School of Medicine.', 'institution_ids': ['https://openalex.org/I89630735']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5079462679', 'display_name': 'H Uemura', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Uemura H', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110168729', 'display_name': 'M. Takeda', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Takeda M', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5062556988', 'display_name': 'Yuichiro Sekiguchi', 'orcid': 'https://orcid.org/0000-0002-2648-3835'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Sekiguchi Y', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006227724', 'display_name': 'Kosuke Ogawa', 'orcid': 'https://orcid.org/0000-0003-2482-2909'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ogawa K', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5110287259', 'display_name': 'Masahiko Hosaka', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Hosaka M', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 3, 'citation_normalized_percentile': {'value': 0.534252, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 69, 'max': 72}, 'biblio': {'volume': '46', 'issue': '9', 'first_page': '605', 'last_page': '7'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9561, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9561, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/discontinuation', 'display_name': 'Discontinuation', 'score': 0.8631873}, {'id': 'https://openalex.org/keywords/chlormadinone-acetate', 'display_name': 'Chlormadinone acetate', 'score': 0.6697087}], 'concepts': [{'id': 'https://openalex.org/C2779322244', 'wikidata': 'https://www.wikidata.org/wiki/Q574820', 'display_name': 'Antiandrogen', 'level': 4, 'score': 0.8806088}, {'id': 'https://openalex.org/C2778715236', 'wikidata': 'https://www.wikidata.org/wiki/Q55622662', 'display_name': 'Discontinuation', 'level': 2, 'score': 0.8631873}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.84734523}, {'id': 'https://openalex.org/C126894567', 'wikidata': 'https://www.wikidata.org/wiki/Q105650', 'display_name': 'Urology', 'level': 1, 'score': 0.73909414}, {'id': 'https://openalex.org/C2780146029', 'wikidata': 'https://www.wikidata.org/wiki/Q5102980', 'display_name': 'Chlormadinone acetate', 'level': 4, 'score': 0.6697087}, {'id': 'https://openalex.org/C2777562237', 'wikidata': 'https://www.wikidata.org/wiki/Q835051', 'display_name': 'Hyperplasia', 'level': 2, 'score': 0.57336533}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.5625382}, {'id': 'https://openalex.org/C2781406297', 'wikidata': 'https://www.wikidata.org/wiki/Q409450', 'display_name': 'Prostate-specific antigen', 'level': 4, 'score': 0.517026}, {'id': 'https://openalex.org/C2776235491', 'wikidata': 'https://www.wikidata.org/wiki/Q9625', 'display_name': 'Prostate', 'level': 3, 'score': 0.44398367}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.34313387}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.25191808}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.15959397}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C2986740045', 'wikidata': 'https://www.wikidata.org/wiki/Q31207', 'display_name': 'Health services', 'level': 3, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000500', 'descriptor_name': 'Allylestrenol', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D002715', 'descriptor_name': 'Chlormadinone Acetate', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D045167', 'descriptor_name': 'Progesterone Congeners', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D017430', 'descriptor_name': 'Prostate-Specific Antigen', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': True}, {'descriptor_ui': 'D011470', 'descriptor_name': 'Prostatic Hyperplasia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000369', 'descriptor_name': 'Aged, 80 and over', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000500', 'descriptor_name': 'Allylestrenol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000726', 'descriptor_name': 'Androgen Antagonists', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002715', 'descriptor_name': 'Chlormadinone Acetate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004334', 'descriptor_name': 'Drug Administration Schedule', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045167', 'descriptor_name': 'Progesterone Congeners', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017430', 'descriptor_name': 'Prostate-Specific Antigen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011470', 'descriptor_name': 'Prostatic Hyperplasia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011470', 'descriptor_name': 'Prostatic Hyperplasia', 'qualifier_ui': 'Q000097', 'qualifier_name': 'blood', 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11107528', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3014716101', 'https://openalex.org/W2738469473', 'https://openalex.org/W2412271360', 'https://openalex.org/W2390799543', 'https://openalex.org/W2386364393', 'https://openalex.org/W2372081072', 'https://openalex.org/W2167588257', 'https://openalex.org/W1982816235', 'https://openalex.org/W1975342515', 'https://openalex.org/W128532551'], 'abstract_inverted_index': {'We': [0, 27, 83, 143], 'compared': [1, 187], 'the': [2, 25, 30, 68, 90, 130, 138, 179, 189], 'prostate': [3, 211], 'specific': [4], 'antigen': [5], '(PSA)': [6], 'levels': [7, 35, 50, 170, 177], 'in': [8, 175, 200], 'benign': [9], 'prostatic': [10], 'hyperplasia': [11], '(BPH)': [12], 'patients': [13, 46, 91, 100, 166, 195], 'with': [14, 47, 53, 86, 167, 188, 196], 'antiandrogen': [15, 42, 185, 205], 'chlormadinone': [16], 'acetate': [17], '(CMA)': [18], 'or': [19, 55], 'allylestrenol': [20], '(AE)': [21], 'before': [22], 'and': [23, 38, 89, 126], 'during': [24, 37], 'treatment.': [26], 'also': [28], 'investigated': [29], 'serial': [31], 'change': [32], 'of': [33, 41, 140, 161, 184, 204], 'PSA': [34, 49, 63, 109, 149, 169, 176, 201], 'before,': [36], 'after': [39, 67, 159, 182, 202], 'discontinuation': [40, 160, 183, 203], 'therapy.': [43, 162], 'Fifty-one': [44], 'BPH': [45, 165, 194], 'normal': [48, 168, 180], 'were': [51, 92, 101], 'treated': [52], 'CMA': [54], 'AE': [56], 'for': [57, 95, 103, 210], '16': [58, 97], 'weeks.': [59, 98, 105], 'The': [60, 106, 163], 'mean': [61, 107], 'serum': [62, 108], 'level': [64, 110, 132], 'significantly': [65, 112], 'decreased': [66, 111], 'treatment': [69], 'from': [70, 113], '1.9': [71], '+/-': [72, 77, 81, 115, 120, 124, 134], '1.0': [73, 116], 'ng/ml': [74, 79, 117, 122], 'to': [75, 118, 129, 153], '1.1': [76, 119, 135], '0.7': [78], '(M': [80, 123], 'SD).': [82], 'discontinued': [84], 'medication': [85], 'informed': [87], 'consent': [88], 'carefully': [93], 'monitored': [94], 'another': [96], 'Nineteen': [99], 'followed': [102], '32': [104], '2.0': [114], '0.5': [121], 'SD)': [125], 'recovered': [127], 'approximately': [128], 'pretreatment': [131, 190], '(1.7': [133], 'ng/ml)': [136, 158], 'at': [137], 'end': [139], 'this': [141], 'study.': [142], 'found': [144], 'only': [145], 'one': [146], 'patient': [147], 'whose': [148], 'was': [150], 'slightly': [151], 'elevated': [152], 'a': [154, 197], 'subnormal': [155], 'range': [156], '(4.3': [157], 'other': [164], 'showed': [171], 'no': [172], 'excessive': [173], 'increase': [174, 199], 'beyond': [178], 'limit': [181], 'therapy': [186, 206], 'baseline.': [191], 'In': [192], 'conclusion,': [193], 'marked': [198], 'should': [207], 'be': [208], 'checked': [209], 'cancer.': [212]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2412271360', 'counts_by_year': [], 'updated_date': '2024-12-08T10:50:00.197439', 'created_date': '2016-06-24'}